See All Slides - tctmd.com

Slides

Presentation TCT 2013

TCT-113. Clinical and Left Ventricular Functional Outcomes Associated with Cardiac Biomarker Elevation after Transfemoral TAVR: A Sub-analysis from the PARTNER Trial

Presenter: Alan Zajarias

October 29, 2013

Presentation TCT 2013

Use Of 4 French Systems For Treating Fem-Pop Lesions: Advantages And Disadvantages: Lessons From The 4EVER Trial Using Astron Pulsar Stents And No Closure Devices

Presenter: Koen Keirse

October 29, 2013

Presentation TCT 2013

Profile of Patients with Atrial Fibrillation in 2013: From the Highly Symptomatic Athlete to the Asymptomatic 85-Year-Old

Presenter: Mintu Turakhia

October 29, 2013

Presentation TCT 2013

TCT-67. The First Establishment of Early Healing Profile, 9-month Neointimal Growth, and 24 Months Outcomes of the Dual Therapy Endothelial Progenitor Cell Capturing...

Presenter: Stephen Lee

October 29, 2013

Presentation TCT 2013

Case 4: TAVR with Sapien 3 (St. Paul's Hospital/University of British Columbia, Vancouver, Canada)

Presenter: Marian Hawkey

October 29, 2013

Presentation TCT 2013

Prognostic impact of chronic total occlusion in ischemic heart disease - A report from the Swedish Coronary Angiography and Angioplasty Registry

Presenter: Truls R?munddal

October 29, 2013

Presentation

Case 1: A Bleeding Patient Post-DES

Presenter: David Kandzari

October 29, 2013

Presentation TCT 2013

When and How Should We Treat Functional MR? Perspective from a Heart Failure Specialist

Presenter: Ulrich Jorde

October 29, 2013

Presentation TCT 2013

Do We Need a Trial of FFR-Guided Surgical Revascularization? The CTSN Network Proposal

Presenter: Michael Argenziano

October 29, 2013

Presentation TCT 2013

Prognostic impact of chronic total occlusion in ischemic heart disease and different age categories - A report from the Swedish Coronary Angiography and Angioplasty Registry

Presenter: Loes Hoebers

October 29, 2013

Advertisement

Slides

TCT-113. Clinical and Left Ventricular Functional Outcomes Associated with Cardiac Biomarker Elevation after Transfemoral TAVR: A Sub-analysis from the PARTNER Trial

Use Of 4 French Systems For Treating Fem-Pop Lesions: Advantages And Disadvantages: Lessons From The 4EVER Trial Using Astron Pulsar Stents And No Closure Devices

Profile of Patients with Atrial Fibrillation in 2013: From the Highly Symptomatic Athlete to the Asymptomatic 85-Year-Old

TCT-67. The First Establishment of Early Healing Profile, 9-month Neointimal Growth, and 24 Months Outcomes of the Dual Therapy Endothelial Progenitor Cell Capturing...

Case 4: TAVR with Sapien 3 (St. Paul's Hospital/University of British Columbia, Vancouver, Canada)

Prognostic impact of chronic total occlusion in ischemic heart disease - A report from the Swedish Coronary Angiography and Angioplasty Registry

Case 1: A Bleeding Patient Post-DES

When and How Should We Treat Functional MR? Perspective from a Heart Failure Specialist

Do We Need a Trial of FFR-Guided Surgical Revascularization? The CTSN Network Proposal

Prognostic impact of chronic total occlusion in ischemic heart disease and different age categories - A report from the Swedish Coronary Angiography and Angioplasty Registry

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content